The Orthopaedic Implant Company Launches Suture Anchor
The Orthopaedic Implant Company commenced launch of a 5.5mm PEEK Suture Anchor. Mar 13, 2019
Smith & Nephew Acquires Brainlab Joint Replacement Business
Smith & Nephew will acquire Brainlab's orthopedic joint reconstruction business, enabling both companies to accelerate R&D in digital surgery and augmented reality. Mar 13, 2019
Tyber Medical Awarded NSF Competitive Grant
Tyber Medical was awarded a $225,000 grant to support research and development relating to a reduction in orthopedic surgical site infections. Mar 13, 2019
Stryker Introduces Platform of Arthroscopy Visualization Tools
Stryker launched a suite of visualization tools to support arthroscopic procedures, including HipCheck, HipMap, the 1688 Advanced Imaging Modalities 4K Visualization Platform and the Connected OR Hub. Mar 12, 2019
Arthrosurface Launches Patellofemoral WaveKahuna Arthroplasty Implant
Arthrosurface introduced its next-generation cementless Patellofemoral WaveKahuna arthroplasty system. Mar 12, 2019
Exactech Acquires XpandOrtho
Exactech acquired XpandOrtho, a designer of soft tissue balancing instruments for knee replacement. Mar 12, 2019
OrthoSensor Shares New VERASENSE Clinical Highlights
New clinical data suggest that use of OrthoSensor's VERASENSE sensor-assisted technology for total knee replacement helps address tissue balance and improve patient outcomes. Mar 12, 2019
AlloSource Announces 2-Year Shelf Life for ProChondrix CR Allograft
AlloSource revealed that ProChondrix® CR fresh cryopreserved osteochondral allograft now has a two-year shelf life, based on the results of real-time testing. Mar 12, 2019
MTF Biologics Debuts CartiMax Viable Cartilage Allograft
MTF Biologics and ConMed launched CartiMax® Viable Cartilage Allograft, an off-the-shelf putty-like cartilage for use in the knee, foot and ankle. Mar 12, 2019
Smith & Nephew to Acquire Osiris
Smith & Nephew entered into an agreement to acquire Osiris Therapeutics, developer of regenerative medicine products including skin, bone graft and articular cartilage substitutes. The transaction is expected to close in 2Q19. Mar 12, 2019
